DE69637316D1 - Vorbeugung und behandlung von kardiovaskulären beschwerden mit tamoxifen-analogen - Google Patents

Vorbeugung und behandlung von kardiovaskulären beschwerden mit tamoxifen-analogen

Info

Publication number
DE69637316D1
DE69637316D1 DE69637316T DE69637316T DE69637316D1 DE 69637316 D1 DE69637316 D1 DE 69637316D1 DE 69637316 T DE69637316 T DE 69637316T DE 69637316 T DE69637316 T DE 69637316T DE 69637316 D1 DE69637316 D1 DE 69637316D1
Authority
DE
Germany
Prior art keywords
tamoxifes
analogs
preventing
treating cardiovascular
cardiovascular complaints
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69637316T
Other languages
English (en)
Other versions
DE69637316T2 (de
Inventor
David J Grainger
James C Metcalfe
Lawrence L Kunz
Paul R Kemp
Robert W Schroff
Peter L Weissberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poniard Pharmaceuticals Inc
Original Assignee
Poniard Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/476,735 external-priority patent/US5595722A/en
Priority claimed from US08/477,393 external-priority patent/US6395494B1/en
Priority claimed from US08/486,334 external-priority patent/US5770609A/en
Application filed by Poniard Pharmaceuticals Inc filed Critical Poniard Pharmaceuticals Inc
Priority claimed from PCT/US1996/010211 external-priority patent/WO1996040098A2/en
Publication of DE69637316D1 publication Critical patent/DE69637316D1/de
Application granted granted Critical
Publication of DE69637316T2 publication Critical patent/DE69637316T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
DE69637316T 1995-06-07 1996-06-07 Vorbeugung und behandlung von kardiovaskulären beschwerden mit tamoxifen-analogen Expired - Lifetime DE69637316T2 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US47893695A 1995-06-07 1995-06-07
US476735 1995-06-07
US08/476,735 US5595722A (en) 1993-01-28 1995-06-07 Method for identifying an agent which increases TGF-beta levels
US486334 1995-06-07
US478936 1995-06-07
US08/477,393 US6395494B1 (en) 1993-05-13 1995-06-07 Method to determine TGF-β
US477393 1995-06-07
US08/486,334 US5770609A (en) 1993-01-28 1995-06-07 Prevention and treatment of cardiovascular pathologies
PCT/US1996/010211 WO1996040098A2 (en) 1995-06-07 1996-06-07 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues

Publications (2)

Publication Number Publication Date
DE69637316D1 true DE69637316D1 (de) 2007-12-20
DE69637316T2 DE69637316T2 (de) 2008-08-28

Family

ID=39646381

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69637316T Expired - Lifetime DE69637316T2 (de) 1995-06-07 1996-06-07 Vorbeugung und behandlung von kardiovaskulären beschwerden mit tamoxifen-analogen

Country Status (2)

Country Link
EP (1) EP1980246A1 (de)
DE (1) DE69637316T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3610266A4 (de) * 2017-04-12 2021-04-21 Massachusetts Eye and Ear Infirmary Tumorsignatur für metastasen, zusammensetzungen von substanzen und verwendung davon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262319A (en) * 1985-04-19 1993-11-16 Oncogene Science, Inc. Method for obtaining bone marrow free of tumor cells using transforming growth factor β3
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
ES2149167T3 (es) * 1990-11-16 2000-11-01 Celtrix Pharma Factor transformante del crecimiento tipo beta.
DE69435137D1 (de) * 1993-05-13 2008-10-16 Poniard Pharmaceuticals Inc Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind

Also Published As

Publication number Publication date
EP1980246A1 (de) 2008-10-15
DE69637316T2 (de) 2008-08-28

Similar Documents

Publication Publication Date Title
DE69500089T3 (de) Behandlung von Geflügel
DE69520296T2 (de) Oberflächenbehandlungsmittel und Oberflächenbehandlung von Halbleiter
DE69415157T2 (de) Elektrochirurgischer prozessor und anwendung
FI964874A (fi) Vihannesten käsittely
DE69430903D1 (de) Behandlung von periodontitis mit misoprostol
ATA11989A (de) Mittel zur vorbeugung gegen und behandlung von parodontopathien
DE69635927D1 (de) Waschverfahren und zusammensetzung hierfür
DE69619051T2 (de) Behandlung von Füllstoffen mit Oxasilacycloalkanen
DE69525349T2 (de) Behandlung von sclaganfall mit einer infiltration von makrophagen assoziiert
DE69739850D1 (de) Anti-reflektierende Behandlung von reflektierenden Oberflächen
DE69518438D1 (de) Behandlung von übereregten nervenzellenfunktionen
DE69717846T2 (de) Behandlungsverfahren von laktamen
DE29512759U1 (de) Sitzanordnung von Belustigungsvorrichtungen
DE69412178D1 (de) Apparat zur Behandlung von Lagen
DE69637316D1 (de) Vorbeugung und behandlung von kardiovaskulären beschwerden mit tamoxifen-analogen
DE69520835D1 (de) Topfschliefscheibe und entsprechendes verschleissteil
DE69306831D1 (de) Behandlung von Flüssigkeiten
DE69306260T2 (de) Behandlung von abwasser
DE69802300T2 (de) Behandlung von schädlichen flüssigkeiten
DE19680394D2 (de) Mittel zur Behandlung von Strahlenschäden
DE69503929T2 (de) Behandlung von Gasmischungen
DE59501763D1 (de) Oligomerisate und Polymerisate von Aminoalkenen
DE69318644T2 (de) Behandlung von Flüssigkeiten
DE59803609D1 (de) Behandlung von Kunststoffoberflächen
KR950026323U (ko) 등산용 양말

Legal Events

Date Code Title Description
8364 No opposition during term of opposition